As the Global Chief Technology Officer at global pharmaceutical giant Johnson & Johnson, Rowena Yeo, 55, leads teams in crafting and executing technology solutions that improve customer and patient care. She previously served as Global Group Chief Information Officer at Cargill, the US-headquartered food MNC for more than two decades. Johnson & Johnson has its regional headquarters and innovation hub in Singapore.
1. How did you come to join Johnson & Johnson (J&J) and what opportunities have you had here? What were some challenges you had to overcome when you first joined the company?
I joined J&J in 2016 as the Asia Pacific Chief Information Officer (CIO) for J&J Innovative Medicine after more than two decades at Cargill. My time at Cargill was meaningful and played a huge role in shaping my career, which made the decision to start anew at J&J a hard one. However, I was drawn to J&J’s credo and the company’s strong passion for improving patient health outcomes. In 2019, I was appointed Global Chief Technology Officer (CTO).
J&J views technology as a key enabler in innovating for impact, allowing our technology team to collaborate closely with the business in shaping the future of healthcare. I have had many opportunities to work on innovative projects that utilise technology to improve employee experience, productivity and patient outcomes. I also get to lead a global team of talented and passionate people who share the same vision as me.
Working through the COVID-19 pandemic was one of the biggest challenges I have faced in my career. During the pandemic, we had to rapidly mobilise our teams to support our 150,000-strong workforce through a sudden transition to remote work. Additionally, the pandemic saw significant disruptions to global supply chains, and the technology team played a pivotal role in ensuring the continued delivery of essential, life-saving products and services to our customers and patients.